Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-κB/nuclear factor-κB-sensitive pathway in alveolar epithelial cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 300, Issue 2, 2002, Pages 567-576

  Haddad, John J ^a   Land, Stephen C ^b   Tarnow Mordi, William O ^c   Zembala, Marek ^d   Kowalczyk, Danuta ^d   Lauterbach, Ryszard ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOBUTYL 8 METHOXYMETHYL 1 METHYLXANTHINE; 4 [[3',4' (METHYLENEDIOXY)BENZYL]AMINO] 6 METHOXYQUINAZOLINE; AMRINONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PENTOXIFYLLINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE III; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; ROLIPRAM; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG; ZAPRINAST;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; FETUS; IMMUNOPHARMACOLOGY; LUNG ALVEOLUS CELL TYPE 2; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL NUCLEUS; CELLS, CULTURED; CYTOSOL; DNA; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; INFLAMMATION; ISOENZYMES; LIPOPOLYSACCHARIDES; NF-KAPPA B; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORYLATION; PULMONARY ALVEOLI; RATS; SIGNAL TRANSDUCTION; TRANSLOCATION, GENETIC;

EID: 0036151665     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.300.2.567     Document Type: Article

References (34)

1. The NF-κB and IκB proteins: New discoveries and insights
2. The transcription factor NF-κB and human disease
3. A family of human phosphodiesterases homologues to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs
4. Asthma, adenosine, mast cells and theophylline
5. Differential expression of cyclic nucleotide phosphodiesterase 3 and 4 activities in human T cell clones specific for myelin basic protein
6. Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation
7. 2-evoked regulation of HIF-1α and NF-κB in perinatal lung epithelium requires glutathione biosynthesis
8. The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-κB (ReIA)-selective targeting
9. 193-195receptor antagonism in the alveolar epithelium
10. Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity evidence for inhibition by glutathione oxidation in alveolar epithelial cells
11. 2/ROS) dependent release of IL-1β, IL-6 and TNF-α: Evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium
12. Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium
13. The biphasic immunoregulation of pyrimidylpiperazine (Y-40138) is IL-10 sensitive and requires NF-κB targeting in the alveolar epithelium
14. Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity
15. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes
16. NF-κB as a therapeutic target in chronic inflammation: Recent advances
17. Pimobendan inhibits the activation of transcription factor NF-κB: A mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase
18. Multiple signals converging on NF-κB
19. Transcriptional regulation by cyclic AMP
20. Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type replication and cytokine production in primary T cells: Involvement of NF-κB and NFAT
21. ReIA/p65 is a molecular target for the immunosuppressive action of protein kinase A
22. Cardiovascular cyclic nucleotide phosphodiesterases and their role in regulating cardiovascular function
23. The ReI/NF-κB family friend and foe
24. Chemotherapeutic potential of phosphodiesterase inhibitors
25. NF-κB A key role in inflammatory disease
26. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV
27. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
28. Structure, regulation and function of NF-κB
29. Functional assay of NF-κB translocation into nuclei by laser scanning cytometry: Inhibitory effect by dexamethasone and theophylline
30. c-ReI is a target of pentoxifylline-mediated inhibition of T lymphocyte activation
31. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
32. Pentoxifylline augments but does not antagonize TNF-α-mediated neuroblastoma cell differentiation: Modulation of calcium mobilization but not cAMP
33. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phoshorylation and NF-κB activation
34. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism